SEC Comment Letter for CASSAVA SCIENCES INC (FLNA) (CIK 0001069530) (FLNA) — Apr 25, 2017
CASSAVA SCIENCES INC (FLNA) (CIK 0001069530)
Date: April 25, 2017 · CIK: 0001069530 · Accession: 0000000000-17-014326
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217319
Letter
Mail Stop 4546 April 25 , 2017 Remi Barbier President, Chief Executive Officer and Chairman Pain Therapeutics, Inc. 7801 N Capital of Texas Highway, Suite 260 Austin, TX 78731
Re: Pain Therapeutics, Inc. Registration Statement on Form S-3 Filed April 14 , 2017 File No. 333-217319
Dear Mr. Barbier :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at (202) 551 -5019 with any questions.
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
Mail Stop 4546 April 25 , 2017 Remi Barbier President, Chief Executive Officer and Chairman Pain Therapeutics, Inc. 7801 N Capital of Texas Highway, Suite 260 Austin, TX 78731 Re: Pain Therapeutics, Inc. Registration Statement on Form S-3 Filed April 14 , 2017 File No. 333-217319 Dear Mr. Barbier : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at (202) 551 -5019 with any questions. Sincerely, /s/ Mary Beth Breslin for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Ze’-ev D. Eiger , Esq. Morrison & Foerster LLP